Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients.
J Clin Gastroenterol
; 36(1): 41-3, 2003 Jan.
Article
em En
| MEDLINE
| ID: mdl-12488707
Saccharomyces cerevisiae is widely used as a probiotic compound. Clinical data suggest that this agent is safe and effective. We report two cases of fungemia caused by S. cerevisiae occurring in immunosuppressed patients treated orally with S. boulardii Molecular typing confirmed clonality in isolate strains from patients and the capsule. Physicians caring for immunosuppressed patients must be aware of this potential serious complication of probiotic use.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Saccharomyces
/
Saccharomyces cerevisiae
/
Hospedeiro Imunocomprometido
/
Fungemia
/
Probióticos
Limite:
Adult
/
Female
/
Humans
/
Male
Idioma:
En
Revista:
J Clin Gastroenterol
Ano de publicação:
2003
Tipo de documento:
Article
País de afiliação:
Chile
País de publicação:
Estados Unidos